Alaunos Therapeutics (TCRT) Selling, General & Administrative (2009 - 2026)
Alaunos Therapeutics (TCRT) posted Selling, General & Administrative of $564,000 for Q2 2026, down 34.0% from $854,000 a year earlier and down 3.6% from the prior quarter.
Alaunos Therapeutics (TCRT) Selling, General & Administrative (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Alaunos Therapeutics was $2.42 million, down 30.0% year-over-year; for FY2025, it came in at $2.87 million, down 35.7% from FY2024.
- Annual Selling, General & Administrative has declined for five consecutive years, with a five-year compound annual growth rate of -36.5% (FY2020 to FY2025).
- In prior years, Alaunos Therapeutics' Selling, General & Administrative was $4.46 million in FY2024 (-63.5%), $12.22 million in FY2023 (-7.0%), $13.14 million in FY2022 (-52.3%) and $27.56 million in FY2021 (-0.4%).
- Quarterly Selling, General & Administrative has run from a low of $549,000 in Q4 2025 to a high of $8.17 million in Q3 2021 over five years.
- On a year-over-year basis, Selling, General & Administrative has declined in each of the last 11 quarters, with an average decline of 40.5% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2022, with growth of 39.6%; the weakest was Q4 2021, with a decline of 76.2%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $585,000 (Q1 2026), $549,000 (Q4 2025) and $718,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Alaunos Therapeutics | 4.16 Mn | 357,198.54 | - | 564,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 564,000.00 |
| Mar 31, 2026 | 585,000.00 |
| Dec 31, 2025 | 549,000.00 |
| Sep 30, 2025 | 718,000.00 |
| Jun 30, 2025 | 854,000.00 |
| Mar 31, 2025 | 747,000.00 |
| Dec 31, 2024 | 845,000.00 |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 990,000.00 |
| Mar 31, 2024 | 1.62 Mn |
| Dec 31, 2023 | 2.43 Mn |
| Sep 30, 2023 | 3.58 Mn |
| Jun 30, 2023 | 3.05 Mn |
| Mar 31, 2023 | 3.17 Mn |
| Dec 31, 2022 | 2.93 Mn |
| Sep 30, 2022 | 3.28 Mn |
| Jun 30, 2022 | 3.43 Mn |
| Mar 31, 2022 | 3.51 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 8.17 Mn |
Alaunos Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TCRT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();